Up-to-date global epidemiology of nonalcoholic fatty liver disease
Richie Manikat(Stanford University), Donghee Kim(Chungnam National University), Aijaz Ahmed(Stanford University)
Cited by 24
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Nonalcoholic fatty liver disease and non-liver comorbidities
|Clinical and Molecular Hepatology|2023|37
The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
|Journal of Pediatric Gastroenterology and Nutrition|2024|25